UK expansion Affidea is actively expanding its UK footprint with new diagnostic clinics in Whitstable and St. Asaph, plus an ambulatory surgical centre in Wimbledon opening in autumn 2026, signaling ongoing growth opportunities in the UK market.

Strategic partnerships Recent collaboration with London International Patient Services Limited indicates a channel for international patient referrals and co-branded services, presenting a path for joint marketing and cross-sell opportunities.

Integrated services Acquisitions like Berner Urologen AG and expansion of integrated urology services strengthen a one-stop diagnostic and specialty care model, suggesting opportunities to upsell imaging, diagnostics, and dedicated outpatient care bundles.

Technology readiness Affidea uses a mix of enterprise tools (PowerPoint, SharePoint, AD) alongside imaging-specific tech and AI-enabled workflows showcased in RSNA activities, implying opportunities to introduce interoperable imaging IT, data analytics, and AI-assisted diagnostics to potential buyers.

Financial scale With a substantial footprint across 366 centers in 15 countries and annual patient volumes approaching 14 million, there is a strong case for enterprise-wide contracts for imaging services, outsourced diagnostics, and centralized procurement with multi-country coverage.